Patrick Wood
Stock Analyst at UBS
(0.81)
# 4,122
Out of 4,662 analysts
435
Total ratings
52.1%
Success rate
-1.7%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Reiterated: Buy | $101 | $87.81 | +15.02% | 14 | Aug 20, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $190 → $205 | $187.60 | +9.28% | 17 | Aug 12, 2026 | |
| PODD Insulet | Rated: Hold | $150 | $151.51 | -1.00% | 17 | Aug 12, 2026 | |
| TFX Teleflex | Maintained: Hold | $145 → $158 | $135.86 | +16.30% | 16 | Aug 11, 2026 | |
| SI Shoulder Innovations | Rated: Buy | $27 → $28 | $23.26 | +20.38% | 8 | Aug 10, 2026 | |
| STE STERIS | Rated: Buy | $275 → $270 | $236.91 | +13.97% | 12 | Aug 7, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $18 | $23.46 | -23.27% | 15 | Aug 7, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Buy | $115 → $120 | $100.74 | +19.12% | 11 | Aug 6, 2026 | |
| SGHT Sight Sciences | Maintained: Buy | $7 → $8 | $8.47 | -5.55% | 10 | Aug 6, 2026 | |
| RXST RxSight | Maintained: Hold | $5.5 → $6.3 | $6.16 | +2.27% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $16 | $9.75 | +64.10% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $80 → $77 | $93.97 | -18.06% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $21.91 | -8.72% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $25 | $19.91 | +25.57% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 → $67 | $52.01 | +28.82% | 21 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $72 → $172 | $189.55 | -9.26% | 10 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 → $23 | $17.45 | +31.81% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $137 → $125 | $114.43 | +9.24% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 → $25 | $26.64 | -6.16% | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $26.50 | +92.45% | 1 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $83 → $75 | $76.73 | -2.25% | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $96 | $89.88 | +6.81% | 16 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $86 → $110 | $92.28 | +19.20% | 17 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $10 → $19 | $17.24 | +10.21% | 4 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $650 → $500 | $397.72 | +25.72% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $117 → $100 | $94.13 | +6.24% | 16 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $13 → $20 | $24.66 | -18.90% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $445 → $400 | $339.98 | +17.65% | 7 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $100 → $82 | $88.34 | -7.18% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $39 | $61.69 | -36.78% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $20.01 | +9.95% | 1 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $20.22 | +23.64% | 1 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 64.95 | CHF 59.38 | +9.38% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $33.91 | +41.55% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $45.53 | -23.13% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $85 | $74.62 | +13.91% | 15 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $205 | $124.75 | +64.33% | 5 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $185 | $290.00 | -36.21% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $220 | $325.07 | -32.32% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $266 | $326.84 | -18.61% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $560 → $656 | $613.54 | +6.92% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $61.25 | n/a | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $13.96 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $249.28 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $1.91 | n/a | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 | $0.036 | n/a | 2 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 | $21.71 | n/a | 1 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $16 | $27.62 | n/a | 2 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 1,473p | 1,069p | n/a | 1 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €35.41 → €45.00 | €23.59 | n/a | 2 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €64.78 → €42.00 | €46.65 | n/a | 2 | Dec 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 267.00 | CHF 579.20 | n/a | 1 | Jan 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.84 | n/a | 1 | Jul 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $177.27 | n/a | 2 | Dec 11, 2017 |
Solventum
Aug 20, 2026
Reiterated: Buy
Price Target: $101
Current: $87.81
Upside: +15.02%
Becton, Dickinson and Company
Aug 12, 2026
Rated: Buy
Price Target: $190 → $205
Current: $187.60
Upside: +9.28%
Insulet
Aug 12, 2026
Rated: Hold
Price Target: $150
Current: $151.51
Upside: -1.00%
Teleflex
Aug 11, 2026
Maintained: Hold
Price Target: $145 → $158
Current: $135.86
Upside: +16.30%
Shoulder Innovations
Aug 10, 2026
Rated: Buy
Price Target: $27 → $28
Current: $23.26
Upside: +20.38%
STERIS
Aug 7, 2026
Rated: Buy
Price Target: $275 → $270
Current: $236.91
Upside: +13.97%
Tandem Diabetes Care
Aug 7, 2026
Reiterated: Hold
Price Target: $18
Current: $23.46
Upside: -23.27%
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $100.74
Upside: +19.12%
Sight Sciences
Aug 6, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $8.47
Upside: -5.55%
RxSight
Aug 6, 2026
Maintained: Hold
Price Target: $5.5 → $6.3
Current: $6.16
Upside: +2.27%
Aug 5, 2026
Rated: Buy
Price Target: $15 → $16
Current: $9.75
Upside: +64.10%
Aug 5, 2026
Rated: Hold
Price Target: $80 → $77
Current: $93.97
Upside: -18.06%
Aug 5, 2026
Reiterated: Hold
Price Target: $20
Current: $21.91
Upside: -8.72%
Aug 4, 2026
Maintained: Buy
Price Target: $24 → $25
Current: $19.91
Upside: +25.57%
Jul 30, 2026
Maintained: Buy
Price Target: $118 → $67
Current: $52.01
Upside: +28.82%
Jul 30, 2026
Maintained: Hold
Price Target: $72 → $172
Current: $189.55
Upside: -9.26%
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $21 → $23
Current: $17.45
Upside: +31.81%
Jul 28, 2026
Rated: Buy
Price Target: $137 → $125
Current: $114.43
Upside: +9.24%
Jul 28, 2026
Rated: Hold
Price Target: $15 → $25
Current: $26.64
Upside: -6.16%
Jul 28, 2026
Initiated Coverage: Buy
Price Target: $51
Current: $26.50
Upside: +92.45%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $83 → $75
Current: $76.73
Upside: -2.25%
Jul 28, 2026
Maintained: Buy
Price Target: $75 → $96
Current: $89.88
Upside: +6.81%
Jul 28, 2026
Upgraded: Buy
Price Target: $86 → $110
Current: $92.28
Upside: +19.20%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $10 → $19
Current: $17.24
Upside: +10.21%
Jul 28, 2026
Upgraded: Buy
Price Target: $650 → $500
Current: $397.72
Upside: +25.72%
Jul 28, 2026
Upgraded: Buy
Price Target: $117 → $100
Current: $94.13
Upside: +6.24%
Jul 28, 2026
Initiated Coverage: Sell
Price Target: $13 → $20
Current: $24.66
Upside: -18.90%
Jul 28, 2026
Upgraded: Buy
Price Target: $445 → $400
Current: $339.98
Upside: +17.65%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $100 → $82
Current: $88.34
Upside: -7.18%
Jul 28, 2026
Downgraded: Sell
Price Target: $39
Current: $61.69
Upside: -36.78%
Jul 28, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $20.01
Upside: +9.95%
Jul 28, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $20.22
Upside: +23.64%
Mar 11, 2026
Maintained: Hold
Price Target: CHF 64.95
Current: CHF 59.38
Upside: +9.38%
Feb 25, 2026
Maintained: Buy
Price Target: $48
Current: $33.91
Upside: +41.55%
Feb 17, 2026
Maintained: Hold
Price Target: $35
Current: $45.53
Upside: -23.13%
Feb 5, 2026
Maintained: Hold
Price Target: $80 → $85
Current: $74.62
Upside: +13.91%
Dec 2, 2025
Maintained: Buy
Price Target: $195 → $205
Current: $124.75
Upside: +64.33%
Nov 11, 2025
Maintained: Hold
Price Target: $185
Current: $290.00
Upside: -36.21%
Nov 11, 2025
Maintained: Buy
Price Target: $195 → $220
Current: $325.07
Upside: -32.32%
Nov 6, 2025
Maintained: Hold
Price Target: $266
Current: $326.84
Upside: -18.61%
Oct 28, 2025
Maintained: Buy
Price Target: $560 → $656
Current: $613.54
Upside: +6.92%
Aug 12, 2025
Maintained: Buy
Price Target: $68
Current: $61.25
Upside: n/a
Aug 4, 2025
Maintained: Hold
Price Target: $12
Current: $13.96
Upside: n/a
Jul 23, 2025
Maintained: Buy
Price Target: $220
Current: $249.28
Upside: n/a
May 27, 2025
Maintained: Hold
Price Target: $6
Current: $1.91
Upside: n/a
Jun 13, 2024
Maintained: Hold
Price Target: $18
Current: $0.036
Upside: n/a
Aug 24, 2023
Downgraded: Hold
Price Target: $34
Current: $21.71
Upside: n/a
Oct 4, 2022
Maintained: Hold
Price Target: $30 → $16
Current: $27.62
Upside: n/a
Feb 22, 2022
Maintained: Buy
Price Target: 1,473p
Current: 1,069p
Upside: n/a
Jul 28, 2021
Downgraded: Hold
Price Target: €35.41 → €45.00
Current: €23.59
Upside: n/a
Dec 3, 2020
Downgraded: Hold
Price Target: €64.78 → €42.00
Current: €46.65
Upside: n/a
Jan 31, 2019
Downgraded: Hold
Price Target: CHF 267.00
Current: CHF 579.20
Upside: n/a
Jul 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $23.84
Upside: n/a
Dec 11, 2017
Upgraded: Buy
Price Target: n/a
Current: $177.27
Upside: n/a